665 related articles for article (PubMed ID: 24196340)
1. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
[TBL] [Abstract][Full Text] [Related]
2. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
3. Topical antifungal treatments for tinea cruris and tinea corporis.
El-Gohary M; van Zuuren EJ; Fedorowicz Z; Burgess H; Doney L; Stuart B; Moore M; Little P
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009992. PubMed ID: 25090020
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
5. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
7. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
Gupta AK; Einarson TR; Summerbell RC; Shear NH
Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
[TBL] [Abstract][Full Text] [Related]
8. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
[TBL] [Abstract][Full Text] [Related]
9. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
Monk JP; Brogden RN
Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
[TBL] [Abstract][Full Text] [Related]
10. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
Ganzinger U; Stutz A; Petranyi G; Stephen A
Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
[TBL] [Abstract][Full Text] [Related]
11. Topical fenticonazole in dermatology and gynaecology: current role in therapy.
Veraldi S; Milani R
Drugs; 2008; 68(15):2183-94. PubMed ID: 18840006
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of interdigital tinea pedis].
Korting HC; Rychlik R; Pfeil B
Dtsch Med Wochenschr; 2003 Sep; 128(36):1819-24. PubMed ID: 12964099
[TBL] [Abstract][Full Text] [Related]
13. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
Jegasothy BV; Pakes GE
Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
[TBL] [Abstract][Full Text] [Related]
14. Naftifine: a review.
Gupta AK; Ryder JE; Cooper EA
J Cutan Med Surg; 2008; 12(2):51-8. PubMed ID: 18346400
[TBL] [Abstract][Full Text] [Related]
15. Naftifine treatment of resistant dermatophytosis.
Rosen T; Fischer M; Orengo I; Abuabara F
Int J Dermatol; 1991 Aug; 30(8):590-2. PubMed ID: 1938060
[TBL] [Abstract][Full Text] [Related]
16. What is the best way to treat tinea cruris?
Nadalo D; Montoya C; Hunter-Smith D
J Fam Pract; 2006 Mar; 55(3):256-8. PubMed ID: 16510062
[TBL] [Abstract][Full Text] [Related]
17. [Topical terbinafine. Reduction of duration of therapy for tinea pedis].
Schmid-Wendtner MH; Korting H
Hautarzt; 2008 Dec; 59(12):986-91. PubMed ID: 18987841
[TBL] [Abstract][Full Text] [Related]
18. Mycological Considerations in the Topical Treatment of Superficial Fungal Infections.
Rosen T
J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s49-55. PubMed ID: 26885799
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
